Benzimidazole

Benzimidazole

SCHEMBL461969

c1ccc2[nH]cnc2c1.c1ccc2[nH]cnc2c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
PDPK1 O15530 1/20 0.50
CA12 O43570 1/20 0.50
PARP1 P09874 1/20 0.50
ALOX15 P16050 1/20 0.50
CA9 Q16790 1/20 0.50
TNKS2 Q9H2K2 1/20 0.50
PRKCI P41743 1/20 0.50
KDM4E B2RXH2 7/20 0.48
MAPT P10636 2/20 0.48
RAD52 P43351 1/20 0.48
ALDH1A1 P00352 6/20 0.47
HPGD P15428 3/20 0.47
RAB9A P51151 3/20 0.47
QPCT Q16769 2/20 0.47
QPCTL Q9NXS2 2/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 2/20 0.46
TP53 P04637 2/20 0.46
MMP12 P39900 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzimidazole SCHEMBL10931770 1.00 SMN1; SMN2 (0.50) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL29408372 1.00
Benzimidazole SCHEMBL29358377 1.00
Benzimidazole SCHEMBL6009 1.00
Benzimidazole SCHEMBL23673327 0.97 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL20531480 0.97 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL5131535 0.97
Benzimidazole SCHEMBL22551123 0.97 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15
Benzimidazole SCHEMBL21046391 0.97
Benzimidazole SCHEMBL9589943 0.97 SMN1; SMN2 (0.48) SMN1; SMN2PDPK1CA12PARP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976153-B2 Fluorinated polymerization catalysts and methods of making and using the same UNIVERSITY OF HOUSTON SYSTEM (US) 2024-05-07 US claimed
US-20230374171-A1 FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF HOUSTON SYSTEM 2023-11-23 US claimed
EP-2173925-B1 CORROSION PROTECTION OF BRONZES MACDERMID ENTHONE INC (US) 2020-09-16 EP claimed
CN-106467549-B A kind of compound containing benzimidazole and its application on organic electroluminescence device 江苏三月光电科技有限公司 2019-03-22 CN claimed
CN-106467548-B A kind of compound containing benzimidazole and its application 江苏三月光电科技有限公司 2019-03-05 CN claimed
CN-106467552-B A kind of compound containing benzimidazole and its application in OLED device 江苏三月光电科技有限公司 2019-02-22 CN claimed
CN-106467549-A A kind of compound containing benzimidazole and its application on organic electroluminescence device 江苏三月光电科技有限公司 2017-03-01 CN claimed
CN-106467548-A A kind of compound containing benzimidazole and its application 江苏三月光电科技有限公司 2017-03-01 CN claimed
CN-106467552-A A kind of compound containing benzimidazole and its application in OLED 江苏三月光电科技有限公司 2017-03-01 CN claimed
US-20100291303-A1 ANTI-TARNISH COATINGS ENTHONE INC. (US) 2010-11-18 US claimed
EP-2246862-A1 Organic electronic device comprising an organic semiconducting material Novaled AG (DE) 2010-11-03 EP claimed
US-20100151263-A1 METALLIC SURFACE ENHANCEMENT ENTHONE INC. (US) 2010-06-17 US claimed
US-20240239923-A1 FLUORINATED POLYMERIZATION CATALYSTS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF HOUSTON SYSTEM 2024-07-18 US disclosed
CN-115838372-B Triphenylethylene derivative and organic electroluminescent device comprising triphenylethylene derivative 广东省大湾区华南理工大学聚集诱导发光高等研究院 2024-05-10 CN disclosed
US-11976153-B2 Fluorinated polymerization catalysts and methods of making and using the same UNIVERSITY OF HOUSTON SYSTEM (US) 2024-05-07 US disclosed
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 US disclosed
EP-0196153-B1 PROCESS FOR THE EXTRACTION OF METAL VALUES AND NOVEL METAL EXTRACTANTS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-07-26 EP disclosed
US-4822880-A 1,1'-SUBSTITUTED 2,2'-BIIMIDAZOLE OR BIBENZIMIDAZOLES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-04-18 US disclosed
US-4696801-A Process for the extraction of metal values with bisimidazole metal extractants IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-09-29 US disclosed
EP-0196153-A2 Process for the extraction of metal values and novel metal extractants IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-10-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles PARG, PARN, NOP2 SMN1; SMN2 1872/4885PDPK1 3377/4885CA12 3144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.